CLINICAL_TRIALS
research
· 2026-03-13
Clinical Trial Update: CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3) [Phase 3]
Summary
A Phase 3 clinical trial (MAVERIC) evaluating CardiolRx for recurrent pericarditis is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cardiol Therapeutics Inc. | Conditions: Recurrent Pericarditis | Phase 3 | Status: RECRUITING